IDA blend vs Norway: Cause of death, by non-communicable diseases, ages 15-59, male
IDA blend
44.3%
in 2021
Norway
71.1%
in 2021
IDA blend rank
28th
Norway rank
30th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- IDA blend
- Norway
How they compare
Norway currently reports 71.1% against 44.3% in IDA blend, a difference of 26.8%.
That makes Norway's figure about 1.6 times IDA blend's.
Across all 6 years both countries report, Norway has been ahead every year.
IDA blend ranks 28th and Norway ranks 30th of 47 groups.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.6% | 75.4% | 38.8% | Norway |
| 2010s | 44.8% | 75.6% | 30.8% | Norway |
| 2020s | 44.5% | 72.5% | 28.0% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, IDA blend or Norway?
- Norway, at 71.1% against 44.3% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between IDA blend and Norway?
- 26.8%, with Norway ahead.
- How many years of comparable data are there for IDA blend and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Norway rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- IDA blend ranks 28th and Norway ranks 30th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.